Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea
Abstract Contradictory findings exist about association of angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) with lung cancer development. This was a retrospective observational cohort study that used data from 7 hospitals in Korea, converted to the Observational...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7df111cbe22e4160bba0f8cee6c946ce |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7df111cbe22e4160bba0f8cee6c946ce |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7df111cbe22e4160bba0f8cee6c946ce2021-12-02T17:23:39ZAngiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea10.1038/s41598-021-97989-82045-2322https://doaj.org/article/7df111cbe22e4160bba0f8cee6c946ce2021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-97989-8https://doaj.org/toc/2045-2322Abstract Contradictory findings exist about association of angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) with lung cancer development. This was a retrospective observational cohort study that used data from 7 hospitals in Korea, converted to the Observational Medical Outcomes Partnership Common Data Model. The primary outcome was occurrence of lung cancer. A total of 207,794 patients across the 7 databases was included in the final analysis; 33,230 (16%) were prescribed ACEi and 174,564 (84%) were prescribed ARB. Crude analysis adjusted for sex and age showed higher incidence of lung cancer in the ACEi group compared to the ARB group (hazard ratio [HR], 1.46; 95% confidence rate [CI], 1.08–1.97). After propensity-score matching, 30,445 pairs were generated, and there was no difference in incidence of lung cancer between the two groups (HR, 0.93; 95% CI, 0.64–1.35). Patients prescribed ACEi showed no difference in incidence of lung cancer development compared to those using ARB. This finding provides evidence on the association between ACEi and occurrence of lung cancer.Seung-Hwa LeeKwang Jin ChunJungchan ParkJinseob KimJi Dong SungRae Woong ParkJinwook ChoiKwangmo YangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Seung-Hwa Lee Kwang Jin Chun Jungchan Park Jinseob Kim Ji Dong Sung Rae Woong Park Jinwook Choi Kwangmo Yang Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea |
description |
Abstract Contradictory findings exist about association of angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) with lung cancer development. This was a retrospective observational cohort study that used data from 7 hospitals in Korea, converted to the Observational Medical Outcomes Partnership Common Data Model. The primary outcome was occurrence of lung cancer. A total of 207,794 patients across the 7 databases was included in the final analysis; 33,230 (16%) were prescribed ACEi and 174,564 (84%) were prescribed ARB. Crude analysis adjusted for sex and age showed higher incidence of lung cancer in the ACEi group compared to the ARB group (hazard ratio [HR], 1.46; 95% confidence rate [CI], 1.08–1.97). After propensity-score matching, 30,445 pairs were generated, and there was no difference in incidence of lung cancer between the two groups (HR, 0.93; 95% CI, 0.64–1.35). Patients prescribed ACEi showed no difference in incidence of lung cancer development compared to those using ARB. This finding provides evidence on the association between ACEi and occurrence of lung cancer. |
format |
article |
author |
Seung-Hwa Lee Kwang Jin Chun Jungchan Park Jinseob Kim Ji Dong Sung Rae Woong Park Jinwook Choi Kwangmo Yang |
author_facet |
Seung-Hwa Lee Kwang Jin Chun Jungchan Park Jinseob Kim Ji Dong Sung Rae Woong Park Jinwook Choi Kwangmo Yang |
author_sort |
Seung-Hwa Lee |
title |
Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea |
title_short |
Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea |
title_full |
Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea |
title_fullStr |
Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea |
title_full_unstemmed |
Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea |
title_sort |
angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in korea |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/7df111cbe22e4160bba0f8cee6c946ce |
work_keys_str_mv |
AT seunghwalee angiotensinconvertingenzymeinhibitorsandincidenceoflungcancerinapopulationbasedcohortofcommondatamodelinkorea AT kwangjinchun angiotensinconvertingenzymeinhibitorsandincidenceoflungcancerinapopulationbasedcohortofcommondatamodelinkorea AT jungchanpark angiotensinconvertingenzymeinhibitorsandincidenceoflungcancerinapopulationbasedcohortofcommondatamodelinkorea AT jinseobkim angiotensinconvertingenzymeinhibitorsandincidenceoflungcancerinapopulationbasedcohortofcommondatamodelinkorea AT jidongsung angiotensinconvertingenzymeinhibitorsandincidenceoflungcancerinapopulationbasedcohortofcommondatamodelinkorea AT raewoongpark angiotensinconvertingenzymeinhibitorsandincidenceoflungcancerinapopulationbasedcohortofcommondatamodelinkorea AT jinwookchoi angiotensinconvertingenzymeinhibitorsandincidenceoflungcancerinapopulationbasedcohortofcommondatamodelinkorea AT kwangmoyang angiotensinconvertingenzymeinhibitorsandincidenceoflungcancerinapopulationbasedcohortofcommondatamodelinkorea |
_version_ |
1718380979250266112 |